baber/WOPTO huggingface dataset:
Patent NZ-582281-A (NZ)
Title: (Thio)-carbamoyl-cyclohexane derivatives and method for treating schizophrenia
Inventor: LASZLOVSZKY ISTVAN
IPC: A61K31/495
Filed: 2008-05-19
Abstract: Disclosed herein is the use of trans-4{ 2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl} -N,N-dimethylcarbamoyl-cyclohexylamine and/or salts thereof, particularly hydrochloride, in a therapeutically effective amount in the manufacture of a medicament for the treatment of schizophrenia, wherein the therapeutically effective amount is in the range of from 1.5 to 12mg/day.
Patent NZ-583804-A (NZ)
Title: A cistern with a cap above overflow tube to maintain a siphon effect during overflow
Inventor: ENGLAND SAM ROBERTSON
IPC: E03D11/18
Filed: 2008-08-26
Abstract: A cistern (8) comprising a cistern tank (10), an overflow tube (16) and a cap (28). The cistern tank (10) has a predetermined maximum fill water level (14). The overflow tube (16) has an inlet (18), above the predetermined maximum water fill level (14), and an outlet (20). The cap (28) is located substantially within the cistern tank (10) and has a lowermost edge (30) spaced horizontally outwardly and vertically upwardly from the overflow tube inlet (18).
Patent NZ-589417-A (NZ)
Title: Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
Inventor: SCHREIBER SOREN
IPC: A61K9/107
Filed: 2009-05-13
Abstract: Disclosed is a stable perfluorcarbon nanoemulsion having an endocytosis enhancing surface, said nanoemulsion having a continuous perfluorcarbon phase and a buffered discontinuous aqueous phase and comprising (a) a perfluorcarbon component comprising at least one least one perfluorcarbon compound; (b) an emulsifying component; and (c) transferrin or a derivative thereof as an endocytosis enhancing component that induces cellular uptake of the nanoemulsion via endocytosis. Also disclosed is a gene-transfer agent or a pharmaceutical composition comprising the nanoemulsion; a method of preparing the nanoemulsion; and the use of a nanoemulsion for preparing a medicament for treating pharmaceutics and genetic material to a patient.
Patent NZ-592005-A (NZ)
Title: Process for the preparation of a N-alkylated ketomorphinan by selective catalytiC hydrogen transfer reduction
Inventor: HUDSON EDMUND C
IPC: C07D489/12
Filed: 2009-09-29
Abstract: ABSTRACT - 592005 Disclosed herein is a process for the preparation of a N-alkylated ketomorphinan comprising Formula (IV), wherein the process comprises the steps of: maintaining a ketone group of a N-imine ketomorphinan or hemiaminal ketomorphinan as unprotected; and, reducing the N-imine ketomorphinan or hemiaminal ketomorphinan in the presence of a hydrogen source, wherein the hydrogen source is a protic compound selected from the group consisting of formic acid, organic or inorganic salts of formic acid, triethylamine, isopropanol, n-propanol, n-butanol, and a combination thereof, and hydrogen is produced in situ through hydrogen transfer and a catalyst without substantially reducing the 6-keto functionality to an alcohol, the N-imine ketomorphinan or hemiaminal ketomorphinan comprising Formula (III) wherein the variables are as defined in the specification.
Patent NZ-592699-A (NZ)
Title: Hinge for cold rooms, swing gates or the like
Inventor: BACCHETTI LUCIANO
IPC: E05D7/08
Filed: 2010-08-04
Abstract: A hinge for cold rooms, swing gates or the like. The hinge comprises a box-like hinge body (3) and a pin (5) reciprocally rotatably coupled to rotate about a first axis (X) between an open door position and a closed door position. Closing means automatically return the door to the closed position. A working fluid acts on the closing means to hydraulically counteract the action thereof and so control the door rotation from the open position to the closed position. The closing means comprise a cam element (11) unitary with the pin (5) interacting with a plunger element (12) housed in an operating chamber (25) defined within the box-like hinge body (3). The closing means and the working fluid are both entirely housed in the operating chamber (25). The box-like hinge body (3) has an elongated shape to define a second axis (Y) perpendicular to the first one (X).
Patent NZ-593570-A (NZ)
Title: Formulations of broad spectrum biocides and their use in improved methods for the treatment of ballast water
Inventor: BRANLY KEITH
IPC: A01N25/04
Filed: 2009-12-18
Abstract: ABSTRACT - 593570 The disclosure relates to a method of treating ballast water in a tank of a seagoing vessel comprising the steps of: (a) adding an effective amount of a suspension concentrate formulation of the compound 2-methyl-1,4-naphthalenedione to the tank, wherein preferably the suspension concentrate comprises 40 to 85 % of the compound 2-methyl-1,4-naphthalenedione and 7 to 9 % of a starch or dihydric alcohol and remaining amount of additives and a carrier; (b) maintaining the ballast water in the tank for a time and at a temperature sufficient to devitalize harmful aquatic organisms and pathogens that may be present in the ballast water; and then (c) expelling the ballast water from the tank to the exterior of the vessel.
Patent NZ-600845-A (NZ)
Title: Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
Inventor: HOLMES ROBERT
IPC: A61K31/365
Filed: 2010-12-16
Abstract: Provided herein are compositions comprising a least one marcolide anthelmintic compound such as ivermectin or a compound of formula (II) and at least one spirodioxepinoindole derivative or a spirooxepinoindole derivative such as 2-desoxoparaherquamide for combating parasites in birds and mammals. The compositions may also comprise an anticestodal agent such as praziquantel or albendazole. Also provided is an improved method for eradicating, controlling and preventing parasite infestation in birds and mammals.
Patent NZ-602895-A (NZ)
Title: Solid milk and the method of manufacturing thereof
Inventor: OHTSUBO KAZUMITSU
IPC: A23C9/18
Filed: 2011-06-13
Abstract: Disclosed is a solid milk, wherein the surface of the solid milk has X-ray diffraction pattern that has a main peak of 2theta = 10-15 degrees at 2theta = 10-11 degrees or at 2 theta = 12-13 degrees. The method for the manufacture of solid milk comprises the steps of: compressing powdered milk so as to obtain solid compressed powdered milk; humidifying the compressed powdered milk so as to obtain humidified compressed powdered milk; and drying the humidified compressed powdered milk so as to obtain the solid milk, wherein a part of amorphous lactose at the surface of the solid milk is crystallized at the steps of humidifying step and drying, wherein the method further comprises a step of cooling the concentrated milk before the step of drying such that the powdered milk obtains crystalline lactose. Alternatively, the crystalline lactose may be added to the powdered milk.
Patent NZ-608412-A (NZ)
Title: Method to separate lipids from cheese whey and fat-free whey protein product formed thereby
Inventor: DAMODARAN SRINIVASAN
IPC: A23C21/00
Filed: 2009-09-18
Abstract: Abstract - 608412, Disclosed is a method of selectively separating milk fat globule membrane fragments and milk fat globules from whey comprising: (a) adding to whey an amount of a whey-soluble zinc salt; and (b) adjusting pH of the whey to be less than 6.0, preferably from about 4.2 to about 4.8; (c) wherein the amount of zinc salt added to the whey is sufficient to cause milk fat globule membrane fragments and milk fat globules contained in the whey to precipitate selectively from the whey.
Patent NZ-614712-A (NZ)
Title: Oligonucleotide modulators of the toll-like receptor pathway
Inventor: AVKIN-NACHUM SHARON
IPC: C12N15/113
Filed: 2012-03-01
Abstract: Disclosed is a double stranded nucleic acid molecule comprising a sense strand and an antisense strand wherein the strands are selected from the oligonucleotides described as TLR2_25 as set forth in SEQ ID NOS:20607 and 20614, TLR2_28 as set forth in SEQ ID NOS:20608 and 20615, TLR2_42 as set forth in SEQ ID NOS:20609 and 20616, TLR2_43 as set forth in SEQ ID NOS:20610 and 20617, TLR2_47 as set forth in SEQ ID NOS:20611 and 20618, TLR2_31 as set forth in SEQ ID NOS:20612 and 20619, and TLR2_34 as set forth in SEQ ID NOS:20613 and 20620; wherein the sequences are as defined in the specification. Also disclosed is its use in therapy.
Patent NZ-616596-A (NZ)
Title: Tube monitor and process measurement and control in or for a reformer
Inventor: TAIT PETER CAMPBELL
IPC: G06F3/00
Filed: 2012-10-12
Abstract: 616596 A method of real time monitoring of the temperature of reformer tubes in a reformer reactor is disclosed. The method in essence comprises measuring the length of each tube and using that measurement to calculate the temperature of the tube. This information can be used to provide a real time indication of the temperature distribution and overheat monitoring/protection of a reformer in real time and allow for estimation of tube life.
Patent NZ-622268-A (NZ)
Title: 5-methoxy, 3’-oh unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing
Inventor: STUPI BRIAN PHILIP
IPC: C07H19/20
Filed: 2012-09-13
Abstract: The disclosure relates to 3’-OH unblocked nucleotides and nucleosides labeled and unlabeled with 5-methoxy-substituted nitrobenzyl-based photocleavable terminating groups (compounds I – VII) for use in methods and systems related to DNA and RNA sequencing and analysis. These compounds may be used as reversible terminators as they exhibit fast nucleotide incorporation kinetics, single-base termination, high nucleotide selectivity, and rapid terminating group cleavage that results in a naturally occurring nucleotide.
Patent NZ-624874-A (NZ)
Title: Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
Inventor: ORWAT MICHAEL J
IPC: C07D491/10
Filed: 2012-10-12
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification. The disclosed compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments for the treatment or prophylaxis of thromboembolic inflammatory disorders. An example of a compound of formula (I) is: (E)-4-(2-(3-(5-chloro-2-(1H-tetrazol-1-yl)phenyl)acryloyl)-5-(piperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamido)benzoic acid
Patent NZ-630057-A (NZ)
Title: Methods to reduce nitrogen impact
Inventor: LEDGARD STEWART FRANCIS
IPC: A01K23/00
Filed: 2014-09-03
Abstract: Use of an intravesicular device in the bladder of a non-human animal to decrease the bladder size and to increase the frequency of urination events and thereby decrease nitrogen deposition rates.
Patent NZ-631505-A (NZ)
Title: Gabion
Inventor: FERRAIOLO FRANCESCO
IPC: E02D29/02
Filed: 2013-03-07
Abstract: A reinforced gabion comprising two adjacent walls with a common edge manufactured using a single sheet of double twisted metal mesh fabric formed from metal wires which have two different diameters respectively corresponding to the two walls. Preferably the metal mesh fabric has a mesh with at least one twisted side formed from at least two metal wires woven together in which each twisted side is aligned in the direction of the common edge between the two walls.
Patent NZ-701239-A (NZ)
Title: Method for producing black-plated steel sheet, and method for producing molded article of black-plated steel sheet
Inventor: YAMAMOTO MASAYA
IPC: C23C28/00
Filed: 2013-04-23
Abstract: The present invention pertains to a method for producing a black-plated steel sheet capable of being blackened in a short amount of time, and exhibiting an excellent ability to maintain a black appearance after processing. As an original sheet, the sheet used is a Zn-plating steel sheet which contains molten Al and Mg and has a Zn-plating layer containing molten Al and Mg, containing Al in the amount of 0.1-22.0 mass%, inclusive, and containing Mg in the amount of 0.1-1.5 mass%, inclusive. The plating layer is blackened by causing the molten-plating steel sheet to contact water vapor inside a tightly sealed container. When doing so, the concentration of oxygen inside the tightly sealed container is 13% or less.
Patent NZ-702736-A (NZ)
Title: Processes and reagents for making diaryliodonium salts
Inventor: DIMAGNO STEPHEN
IPC: C07D413/12
Filed: 2013-05-30
Abstract: The invention relates to processes and reagents for making diaryliodonium salts, which are useful for the preparation of fluorinated and radiofluorinated aromatic compounds. In one embodiment, the invention relates to a process for the preparation of a compound of formula Ar1-I(X)2 (Formula I) by treating a compound of formula Ar1-I (Formula II) with a tetravalent silicon moiety having at least one X group bound to Si.
Patent NZ-704680-A (NZ)
Title: Polymer overmolded bariatric clamp and method of installing
Inventor: ARMENTEROS JESUS R
IPC: A61B17/128
Filed: 2013-08-09
Abstract: A bariatric clamp may include substrate members overmolded in polymer forming first and second elongated portions, a bight portion having a flexible hinge, a fastener portion, and an engagement portion for retaining the clamp in a closed position to partition the stomach. A method for installing may include creating an opening in a patient’s abdominal cavity to access the stomach, removing tissue connected to the stomach adjacent areas the clamp is to be positioned, positioning the clamp in an open position wherein first ends of the first and second elongated portions are open relative to one another, inserting the clamp into the abdominal cavity in the open position and the first and second elongated portions of the clamp separately pass through the opening in the abdominal cavity, positioning the first and second elongated portions adjacent first and second sides of the stomach, and closing the clamp to partition the stomach.
Patent NZ-704810-A (NZ)
Title: A swaging method
Inventor: JEREMY ROBERT KANE KENEALY
IPC: B21J7/18
Filed: 2014-06-19
Abstract: A method of swaging a section of a beam or channel is disclosed. A portion of a beam to be swaged is placed in a swaging apparatus (1) having first (11a, 11b) and second (15) die sets. The first die set is configured to act along a first axis on a portion of the beam in order to alter the profile thereof. The second die set is configured to act on a portion of the beam along a second axis at an angle to the first axis in order to alter the profile thereof. The finishing position of at least one of the die sets is then adjusted to the required position. The swaging apparatus is then operated to swage the portion of the beam. The method allows a user to carry out two shaping operations from the same device, as opposed to using multiple single operation devices.
Patent NZ-719038-A (NZ)
Title: Leaching of minerals
Inventor: HOURN Michael
IPC: C22B11/00
Filed: 2014-10-21
Abstract: ABSTRACT A method for treating a mineral composition containing iron, arsenic or other Group VA compounds comprises milling the mineral composition to a particle size of P80 of less than 25 µm and leaching the mineral composition in the presence of lime and/or limestone and a soluble alkali complexing agent and in the presence of an oxygen containing gas at a pH in the range of from 3.5 to 6.
Patent NZ-720856-A (NZ)
Title: Condensed imidazolylimidazoles as antiviral compounds
Inventor: YANG ZHENG-YU
IPC: C07D491/052
Filed: 2012-11-16
Abstract: Disclosed are specific velpatasvir analogues as antiviral compounds, optionally in combination with sofosbuvir for the treatment of Hepatitis C Virus. Representative compounds of the present application include methyl { (2S)-1-[(2S)-2-(9-{ 2-[(2S,4S)-1-{ (2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl} -4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-4-yl} -1,11-dihydro[2]benzopyrano[4’,3’:6,7]naphtho[1,2-d]imidazol-2-yl)-pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl} carbamate.
Patent NZ-734435-A (NZ)
Title: Improved animal handling device
Inventor: NICHOLAS MARK BLAMPIED
IPC: A01K29/00
Filed: 2017-08-08
Abstract: Described herein is an animal handling device designed to controllably move an animal platform and optionally an animal thereon from a first substantially animal upright position to a second substantially animal inverted position and back about a hinge rotation axis located along the side of the animal platform thereby allowing a user to fully invert an animal in a controlled manner and/or halt movement at positions intermediate the first position and second position as may be desired. More specifically, in one aspect, an animal handling device is described having an animal platform with an elongated base and at least one side attached to a longitudinal side of the elongated base, the animal platform elongated base defining an area configured to accept and allow an animal to stand thereon. The device further comprises a mechanism that communicates movement of at least one actuator to the animal platform, and, on actuation of the at least one actuator, the mechanism moves the animal platform from a first substantially upright position to a second substantially inverted position and, on further actuation, the mechanism via the at least one actuator, moves the animal platform from the second position to the first position. In a further aspect, a method of controllably restraining and rotating an animal using the device is described. The device described herein overcomes limitations in the art around not being able to fully and controllably invert an animal held therein. The device described also completes the movement action with a compact configuration.
Patent NZ-738834-A (NZ)
Title: Nutritional products having improved lipophilic solubility and bioavailability in an easily mixable form
Inventor: VURMA MUSTAFA
IPC: A23L33/19
Filed: 2016-07-28
Abstract: Methods of preparing a nutritional product which contain a lipophilic nutrient are disclosed. The nutritional product is made using a fortifying powder containing the lipophilic nutrient, a monoglyceride and diglyceride (”MDG”) oil, a phospholipid, and a carrier. The fortifying powder enhances the digestive absorption of the lipophilic nutrient when the nutritional product is consumed. The fortifying powder simplifies the process of manufacturing the nutritional product, as the fortifying powder can be added at a suitable stage of the process with other powdered ingredients. The fortifying powder may be manufactured in bulk and stored for later use, thereby improving manufacturing efficiencies. The fortifying powder and methods of preparing the fortifying powder are also presented.
Patent NZ-742115-A (NZ)
Title: Novel citric acid derivative
Inventor: HIRAISHI KATSUYA
IPC: C07D405/04
Filed: 2016-11-01
Abstract: Compounds (citric acid derivatives) represented by formulas (1) and (2) below are novel compounds having an inhibitory effect against liver disorder and can be used as liver disorder inhibitors and food additives (wherein R1 represents a C1 to C3 alkyl group optionally having a carboxyl group or a hydroxyl group, and R2 represents a hydrogen atom, or R1 and R2 optionally form a cyclic structure together to represent a C2 to C3 alkylene chain).
Patent NZ-744677-A (NZ)
Title: Adjustable pit
Inventor: TUNLEY ANDREW
IPC: E03F11/00
Filed: 2017-07-17
Abstract: A silt pit comprising an adjustable portion, including an inlet and a substantially cylindrical neck, and a body portion with an enclosed end, including an outlet spaced from the enclosed end and configured to be set into a surrounding substrate, wherein the adjustable portion and the body portion include mating threads for adjusting the height of the adjustable portion relative to a surface of the surrounding substrate once the body portion is set into the surrounding substrate.
Patent NZ-756943-A (NZ)
Title: Espresso coffee machine with improved system for regulating the temperature of the water and method for regulating the temperature of the water in an espresso coffee machine
Inventor: DIONISIO ANDREA
IPC: A47J31/56
Filed: 2018-03-20
Abstract: An espresso coffee machine is described, said machine comprising: a dispensing group and a corresponding coffee boiler containing water under pressure; a heater device for heating the water in the coffee boiler; a temperature sensor for measuring the temperature of the water in the coffee boiler; a processor connected to said sensor and configured to drive said heater device so that the water in the coffee boiler is at a set reference temperature, wherein said processor comprises a feedback system; and wherein the value of said set reference temperature is varied as a function of at least one of the following parameters: (a) a first parameter which is a function of the time elapsed from an operating cycle of the machine or a frequency of use of the machine within a time interval; (b) a second parameter which is a function of the temperature of a component of the machine; and (c) a third parameter which is a function of the environment.
Patent NZ-763404-A (NZ)
Title: System and methods for using cipher objects to protect data
Inventor: SMITH GREGORY
IPC: H04L9/32
Filed: 2015-04-17
Abstract: A system for improved security of computer systems, comprising a computer-readable medium having computer-executable instructions stored thereon, the instructions comprising a computer-based intelligent cipher transfer object comprising a digital mixture of a set of participants, said set of participants comprising owner data, one or more outer cloaking patterns configured to be applied to the set of participants such that an interim cipher object is created; and a portable dynamic rule set, said portable dynamic rule set comprising an identity module, an intelligence module, and one or more inner cloaking patterns, each inner cloaking pattern including (i) a transformation to be applied to some participants of the set of participants and (ii) a description for reversing the transformation; wherein, in response to execution by one or more processors of the system, the instructions cause the intelligent cipher transfer object to internally perform the steps of: receiving, from an external agent, a request to access some or all of the set of participants; attempting to verify that the external agent is authorized to access some or all of the set of participants as requested; and upon verifying that the external agent is authorized, providing access to some or all of the set of participants for which the external agent has been verified for access, without providing access to unauthorized portions of the set of participants.
Patent NZ-765776-A (NZ)
Title: Use of a neuregulin to treat peripheral nerve injury
Inventor: CAGGIANO ANTHONY
IPC: A61P25/02
Filed: 2010-10-14
Abstract: Disclosed herein is the use of a neuregulin for treating a cavernous nerve injury in a subject, wherein the cavernous nerve injury causes erectile dysfunction, and wherein the cavernous nerve injury is due to a trauma or a medical procedure. Also described is the use of neuragulins to prevent a peripheral nerve injury from a medical or surgical procedure, such as a tumour resection surgery, child birth, wherein the compound is administered prior to the medical or surgical procedure. The neuragulin is preferably GGF2 or an active fragment comprising an epidermal growth-factor like (EGF-like) domain thereof.